FindTrial
Sign In

Comparison of Pheniramine and Hyoscine for management of post operative catheter related bladder discomfort after general anaesthesia.

Comparative evaluation of Pheniramine versus Hyoscine for management of post operative catheter related bladder discomfort after general anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035651
Enrollment
60
Registered
2021-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Comparative evaluation of Pheniramine versus Hyoscine for management of post operative catheter related bladder discomfort after general anaesthesia.: patients in group A will be given

Sponsors

Dayanand Medical college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult male patient between 25-55 years of age posted for elective non- urological surgeries under general anaesthesia. 2. American Society of Anaesthesiologist(ASA) Class I-II.

Exclusion criteria

Exclusion criteria: 1. Clinical evidence of previous lower urinary system diseases needing medical or surgical intervention (such as prostate diseases or urethral stricture), 2. History or current evidence of urinary tract infection (UTI). 3. Bladder outlet obstruction, overactive bladder (urination frequency > 3 times/night or > 8 times in 24 h) 4. Patients already on alpha 1 adrenergic antagonists like tamsulosin. 5. Any difficulty or resistance encountered during catheterization. 6. Morbid obesity (body mass index over 40). 7. Chronic renal failure. 8. History of ischemic heart disease, myocardial infarction, hepatic or psychiatric disease. 9. History of substance abuse, chronic pain or gabapentin use. 10. History of neurologic disease like stroke, parkinsonism, alzeihemerâ??s. 11. History of Bronchial asthma or thyroid disease. 12. History of narrow angle glaucoma. 13. Patients with catheter in-situ before shifting to operating room. 14. History of drug allergy to Diclofenac, Pheniramine and Hyoscine

Design outcomes

Primary

MeasureTime frame
The primary outcome will be measured as reduction in severity of CRBD.Timepoint: The patients will be observed at 30 mnutes ,then at 1 hour then every hourly till 6 hours for CRBD.—

Secondary

MeasureTime frame
The secondary outcome will be measured as dose and frequency of post-operative analgesic (tramadol) used and adverse effects.Timepoint: 6 hours—

Countries

India

Contacts

Public ContactDr Shubham Garg

Dayanand Medical College and Hospital

drsgargsurgery4@gmail.com8360218891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026